173 related articles for article (PubMed ID: 22591220)
1. High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates.
Sánchez-Delgado J; García-Iglesias P; Castro-Fernández M; Bory F; Barenys M; Bujanda L; Lisozain J; Calvo MM; Torra S; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2012 Jul; 36(2):190-6. PubMed ID: 22591220
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
3. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
Sánchez-Delgado J; Calvet X; Bujanda L; Gisbert JP; Titó L; Castro M
Am J Gastroenterol; 2008 Sep; 103(9):2220-3. PubMed ID: 18564109
[TBL] [Abstract][Full Text] [Related]
4. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study.
Chuah SK; Tai WC; Hsu PI; Wu DC; Wu KL; Kuo CM; Chiu YC; Hu ML; Chou YP; Kuo YH; Liang CM; Chiu KW; Hu TH
Helicobacter; 2012 Oct; 17(5):374-81. PubMed ID: 22967121
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.
Chuah SK; Hsu PI; Chang KC; Chiu YC; Wu KL; Chou YP; Hu ML; Tai WC; Chiu KW; Chiou SS; Wu DC; Hu TH
Helicobacter; 2012 Jun; 17(3):216-23. PubMed ID: 22515360
[TBL] [Abstract][Full Text] [Related]
7. New effective treatment regimen for children infected with a double-resistant Helicobacter pylori strain.
Schwarzer A; Urruzuno P; Iwańczak B; Martínez-Gómez MZ; Kalach N; Roma-Giannikou E; Liptay S; Bontem P; Buderus S; Wenzl TG; Koletzko S;
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):424-8. PubMed ID: 21407111
[TBL] [Abstract][Full Text] [Related]
8. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
Schütze K; Hentschel E; Hirschl AM
Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
[TBL] [Abstract][Full Text] [Related]
10. Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
Georgopoulos S; Papastergiou V; Xirouchakis E; Laoudi F; Lisgos P; Spiliadi C; Papantoniou N; Karatapanis S
J Clin Gastroenterol; 2013 Mar; 47(3):228-32. PubMed ID: 22858517
[TBL] [Abstract][Full Text] [Related]
11. Ten-day sequential therapy of Helicobacter pylori infection in Thailand.
Sirimontaporn N; Thong-Ngam D; Tumwasorn S; Mahachai V
Am J Gastroenterol; 2010 May; 105(5):1071-5. PubMed ID: 20010919
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.
Georgopoulos S; Papastergiou V; Xirouchakis E; Laudi F; Papantoniou N; Lisgos P; Spiliadi C; Fragou P; Skorda L; Karatapanis S
Helicobacter; 2012 Feb; 17(1):49-53. PubMed ID: 22221616
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment.
Sacco F; Spezzaferro M; Amitrano M; Grossi L; Manzoli L; Marzio L
Dig Liver Dis; 2010 Feb; 42(2):110-4. PubMed ID: 19846355
[TBL] [Abstract][Full Text] [Related]
14. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.
Polat Z; Kadayifci A; Kantarcioglu M; Ozcan A; Emer O; Uygun A
Eur J Intern Med; 2012 Mar; 23(2):165-8. PubMed ID: 22284248
[TBL] [Abstract][Full Text] [Related]
15. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E
Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942
[TBL] [Abstract][Full Text] [Related]
16. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
17. Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
Nishikawa K; Sugiyama T; Ishizuka J; Kudo T; Komatsu Y; Katagiri M; Sukegawa M; Kagaya H; Kudo M; Kato M; Takeda H; Toyota J; Asaka M
J Gastroenterol; 1999; 34 Suppl 11():72-5. PubMed ID: 10616770
[TBL] [Abstract][Full Text] [Related]
18. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Vakil N; Cutler A
Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
[TBL] [Abstract][Full Text] [Related]
19. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
Sezgin O; Altintaş E; Nayir E; Uçbilek E
Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405
[TBL] [Abstract][Full Text] [Related]
20. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
Kang JM; Kim N; Lee DH; Park YS; Kim YR; Kim JS; Jung HC; Song IS
Helicobacter; 2007 Dec; 12(6):623-8. PubMed ID: 18001404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
